🇺🇸 FDA
Patent

US 11478556

Compositions and methods for treating or ameliorating neuroinflammation, neurodegeneration, neuropathic pain, and migraine

granted A61KA61K38/52A61K48/0058

Quick answer

US patent 11478556 (Compositions and methods for treating or ameliorating neuroinflammation, neurodegeneration, neuropathic pain, and migraine) held by The Regents of the University of California expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/52, A61K48/0058, A61P, A61P25/06